174 related articles for article (PubMed ID: 33206290)
1. Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.
Prakash I; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Hyslop T; Fayanju OM
Breast Cancer Res Treat; 2021 Apr; 186(2):535-550. PubMed ID: 33206290
[TBL] [Abstract][Full Text] [Related]
2. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.
Omarini C; Guaitoli G; Noventa S; Andreotti A; Gambini A; Palma E; Papi S; Tazzioli G; Balduzzi S; Dominici M; Cascinu S; Piacentini F
Eur J Surg Oncol; 2017 Apr; 43(4):613-618. PubMed ID: 27793416
[TBL] [Abstract][Full Text] [Related]
3. Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
Sutton TL; Schlitt A; Gardiner SK; Johnson N; Garreau JR
J Surg Oncol; 2020 Dec; 122(8):1761-1769. PubMed ID: 33125715
[TBL] [Abstract][Full Text] [Related]
4. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
5. Impact of wait time from neoadjuvant chemotherapy to surgery in breast cancer: Does time to surgery affect patient outcomes? : Time from Neoadjuvant Chemotherapy to Surgery.
Lai V; Hajjaj O; Le D; Shokoohi A; Chia S; Simmons C
Breast Cancer Res Treat; 2020 Dec; 184(3):755-762. PubMed ID: 33001336
[TBL] [Abstract][Full Text] [Related]
6. Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.
Wapnir IL; Kurian AW; Lichtensztajn DY; Clarke CA; Gomez SL
Ann Surg; 2017 Aug; 266(2):353-360. PubMed ID: 27611617
[TBL] [Abstract][Full Text] [Related]
7. Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
Golshan M; Cirrincione CT; Sikov WM; Carey LA; Berry DA; Overmoyer B; Henry NL; Somlo G; Port E; Burstein HJ; Hudis C; Winer E; Ollila DW;
Breast Cancer Res Treat; 2016 Nov; 160(2):297-304. PubMed ID: 27704226
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Breast Cancer Treatment Delays on Survival Among South African Women.
Pumpalova YS; Ayeni OA; Chen WC; Buccimazza I; Cačala S; Stopforth LW; Farrow HA; Mapanga W; Nietz S; Phakathi B; Joffe M; McCormack V; Jacobson JS; Crew KD; Neugut AI; Ruff P; Cubasch H; O'Neil DS
Oncologist; 2022 Mar; 27(3):e233-e243. PubMed ID: 35274708
[TBL] [Abstract][Full Text] [Related]
9. Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.
Fayanju OM; Ren Y; Suneja G; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hyslop T; Hwang ES
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):377-389. PubMed ID: 31678225
[TBL] [Abstract][Full Text] [Related]
10. Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer.
Champion CD; Thomas SM; Plichta JK; Parrilla Castellar E; Rosenberger LH; Greenup RA; Hyslop T; Hwang ES; Fayanju OM
JCO Oncol Pract; 2022 May; 18(5):e827-e838. PubMed ID: 33026950
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
[TBL] [Abstract][Full Text] [Related]
13. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
Sanford RA; Lei X; Barcenas CH; Mittendorf EA; Caudle AS; Valero V; Tripathy D; Giordano SH; Chavez-MacGregor M
Ann Surg Oncol; 2016 May; 23(5):1515-21. PubMed ID: 26678405
[TBL] [Abstract][Full Text] [Related]
14. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
Mittendorf EA; Buchholz TA; Tucker SL; Meric-Bernstam F; Kuerer HM; Gonzalez-Angulo AM; Bedrosian I; Babiera GV; Hoffman K; Yi M; Ross MI; Hortobagyi GN; Hunt KK
Ann Surg; 2013 Feb; 257(2):173-9. PubMed ID: 23291658
[TBL] [Abstract][Full Text] [Related]
15. Impact of neoadjuvant chemotherapy on breast reconstruction.
Hu YY; Weeks CM; In H; Dodgion CM; Golshan M; Chun YS; Hassett MJ; Corso KA; Gu X; Lipsitz SR; Greenberg CC
Cancer; 2011 Jul; 117(13):2833-41. PubMed ID: 21264833
[TBL] [Abstract][Full Text] [Related]
16. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
[TBL] [Abstract][Full Text] [Related]
17. The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.
Yamaguchi T; Hozumi Y; Sagara Y; Takahashi M; Yoneyama K; Fujisawa T; Osumi S; Akabane H; Nishimura R; Mieno MN; Mukai H
Surg Oncol; 2021 Mar; 36():51-55. PubMed ID: 33310293
[TBL] [Abstract][Full Text] [Related]
18. Factors Affecting Time to Surgery in Breast Cancer Patients.
Chagpar AB; Howard-McNatt M; Chiba A; Levine EA; Gass JS; Gallagher K; Lum S; Martinez R; Willis AI; Fenton A; Solomon NL; Senthil M; Edmonson D; Namm JP; Walters L; Brown E; Murray M; Ollila D; Dupont E; Garcia-Cantu C
Am Surg; 2022 Apr; 88(4):648-652. PubMed ID: 34732082
[TBL] [Abstract][Full Text] [Related]
19. Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy.
Pollom EL; Qian Y; Chin AL; Dirbas FM; Asch SM; Kurian AW; Horst KC; Tsai CJ
Int J Cancer; 2018 Dec; 143(12):3262-3272. PubMed ID: 29992582
[TBL] [Abstract][Full Text] [Related]
20. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
Vila J; Teshome M; Tucker SL; Woodward WA; Chavez-MacGregor M; Hunt KK; Mittendorf EA
Ann Surg; 2017 Mar; 265(3):574-580. PubMed ID: 27735826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
